The authors discuss the California Institute for Regenerative Medicine’s focus on state, national, and international regulatory policy issues impacting basic research and translational medicine.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039461 | PMC |
http://dx.doi.org/10.5966/sctm.2014-0069 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!